Rigel Pharma (RIGL) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $42.02 +0.86%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
WPRT, ITRG, ALM, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
WPRT, ITRG, ALM, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.16), $0.06 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $5.18 million versus the consensus estimate of $2.67 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
- RideNow Group, Inc. (RDNW) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
